Page last updated: 2024-09-03

n-2-hexyl-n-methylpropargylamine and amphetamine

n-2-hexyl-n-methylpropargylamine has been researched along with amphetamine in 1 studies

Compound Research Comparison

Studies
(n-2-hexyl-n-methylpropargylamine)
Trials
(n-2-hexyl-n-methylpropargylamine)
Recent Studies (post-2010)
(n-2-hexyl-n-methylpropargylamine)
Studies
(amphetamine)
Trials
(amphetamine)
Recent Studies (post-2010) (amphetamine)
90013,0713291,977

Protein Interaction Comparison

ProteinTaxonomyn-2-hexyl-n-methylpropargylamine (IC50)amphetamine (IC50)
Phenylethanolamine N-methyltransferaseBos taurus (cattle)0.96
Cytochrome P450 2A6Homo sapiens (human)3.5
Cytochrome P450 2A5Mus musculus (house mouse)2.85
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)0.96
Beta-2 adrenergic receptorCavia porcellus (domestic guinea pig)0.96

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boulton, AA; Davis, BA; Yu, PH1

Reviews

1 review(s) available for n-2-hexyl-n-methylpropargylamine and amphetamine

ArticleYear
Aliphatic propargylamines, a new series of potent selective, irreversible non-amphetamine-like MAO-B inhibitors. Their structures, function and pharmacological implications.
    Advances in experimental medicine and biology, 1995, Volume: 363

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Mice; Monoamine Oxidase Inhibitors; Pargyline; Propylamines; Structure-Activity Relationship

1995